InspireMD Inc. NSPR recently announced the first patient enrolment in the company’s CGUARDIANS II clinical trial. The trial ...

Opening a blocked artery with balloons and stents can be lifesaving but as Gujarat deaths show, cases of misuse are also ...

InspireMD, Inc. announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluati ...

LAS VEGAS, NV—One year after Medicare’s National Coverage Determination (NCD) expanded access in the United States to carotid artery stenting (CAS), data reassure on the safety and efficacy of the ...

The global coronary stents market, valued at $10.1 billion in 2020, is forecast to expand at an impressive CAGR of 12.9% from ...

KOCHI: Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, claiming an estimated 17.9 million ...

InspireMD enrolled the first patient in its CGUARDIANS II pivotal study, which will evaluate the CGuard Prime Carotid Stent ...

Sixty-nine patients had ICA stenting and 14 had CCA stents (these were CCA bifurcated stents). Sixty-three percent were done for ≥ 70% asymptomatic carotid stenosis and 37% for strokes/transient ...

InspireMD (NSPR) announced that the first patient has been enrolled in the company’s CGUARDIANS II clinical trial evaluating its CGuard Prime ...